I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Zangardi, Mark
9
results:
Search for persons
X
Format
Online (9)
Mediatypes
Articles (Online) (7)
OpenAccess-fulltext (2)
Sorted by: Relevance
Sorted by: Year
?
1
Late-onset cardiotoxicity in patients with HER2-positive me..:
Alowais, Shuroug A.
;
Luk, Samantha O.
;
Kim, E. Bridget
..
Journal of Oncology Pharmacy Practice. , 2023
Link:
https://doi.org/10.1177/..
?
2
Evaluation of proteinuria monitoring practice patterns and ..:
Sturgill, Kuan
;
Dicke, Katie
;
Zangardi, Mark
.
Journal of Oncology Pharmacy Practice. , 2023
Link:
https://doi.org/10.1177/..
?
3
The adjuvant use of capecitabine for residual disease follo..:
Beyerlin, Kassidy
;
Jimenez, Rachel
;
Zangardi, Mark
...
Journal of Oncology Pharmacy Practice. 27 (2020) 8 - p. 1883-1890 , 2020
Link:
https://doi.org/10.1177/..
?
4
Ruxolitinib for secondary hemophagocytic lymphohistiocytosi..:
Sin, Jonathan H.
;
Zangardi, Mark L.
Hematology/Oncology and Stem Cell Therapy. 12 (2019) 3 - p. 166-170 , 2019
Link:
https://doi.org/10.1016/..
?
5
CDK 4/6 Inhibitors in Breast Cancer: Current Controversies ..:
Spring, Laura M.
;
Wander, Seth A.
;
Zangardi, Mark
.
Current Oncology Reports. 21 (2019) 3 - p. , 2019
Link:
https://doi.org/10.1007/..
?
6
Pilot Randomized Trial of a Pharmacy Intervention for Older..:
Nipp, Ryan D.
;
Ruddy, Margaret
;
Fuh, Charn-Xin
...
The Oncologist. 24 (2018) 2 - p. 211-218 , 2018
Link:
https://doi.org/10.1634/..
?
7
Clinical Management of Potential Toxicities and Drug Intera..:
Spring, Laura M.
;
Zangardi, Mark L.
;
Moy, Beverly
.
The Oncologist. 22 (2017) 9 - p. 1039-1048 , 2017
Link:
https://doi.org/10.1634/..
?
8
CDK 4/6 Inhibitors in Breast Cancer: Current Controversies ..:
Spring, Laura M
;
Wander, Seth A
;
Zangardi, Mark
.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6573012/. , 2019
Link:
http://www.ncbi.nlm.nih...
?
9
Clinical Management of Potential Toxicities and Drug Intera..:
Spring, Laura M
;
Zangardi, Mark L
;
Moy, Beverly
.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599204/. , 2017
Link:
http://www.ncbi.nlm.nih...
1-9
